Modified interleukin-1beta converting enzyme with increased stability
AssigneeBASF SE
InventorsRobert V. Talanian, John A. Mankovich, Tariq Ghayur, Catherine R. Ferenz
Life of this patent
Estimating the term…
Loading patent…
AssigneeBASF SE
InventorsRobert V. Talanian, John A. Mankovich, Tariq Ghayur, Catherine R. Ferenz
Estimating the term…
Modified forms of human interleukin-1β converting enzyme (ICE) that display proteolytic activity and, furthermore, have increased stability compared to unmodified human ICE are disclosed. Nucleic acid molecules encoding a modified p10 subunit of ICE, and recombinant vectors and host cells incorporating such nucleic acid molecules, are also disclosed. A modified ICE protein of the invention can be used to cleave proteolytically ICE substrates and to identify modulators of ICE activity in screening assays. Moreover, due to its enhanced stability, the modified ICE of the invention is particularly suitable for use in the preparation of ICE crystals for X-ray crystallography.
A modified interleukin-1β converting enzyme (ICE) comprising an amino acid sequence wherein an amino acid corresponding to aspartic acid at position 381 of unmodified ICE (SEQ ID NO:
A modified interleukin-1β converting enzyme (ICE) comprising an amino acid sequence wherein an amino acid corresponding to aspartic acid at position 381 of unmodified ICE (SEQ ID NO:
A modified interleukin-1β converting enzyme (ICE) comprising an amino acid sequence wherein an amino acid corresponding to aspartic acid at position 381 of unmodified ICE (SEQ ID NO:
A nucleic acid molecule encoding a modified p10 subunit of interleukin-1β converting enzyme (ICE), the modified p10 subunit comprising an amino acid sequence wherein an amino acid corresponding to aspartic acid at position 381 of unmodified ICE (SEQ ID NO:
A nucleic acid molecule encoding a modified p10 subunit of interleukin-1β converting enzyme (ICE), the modified p10 subunit comprising an amino acid sequence wherein an amino acid corresponding to aspartic acid at position 381 of unmodified ICE (SEQ ID NO:
A nucleic acid molecule encoding a modified p10 subunit of interleukin-1β converting enzyme (ICE), the modified p10 subunit comprising an amino acid sequence wherein an amino acid corresponding to aspartic acid at position 381 of unmodified ICE (SEQ ID NO:
A method for cleaving an interleukin-1β converting enzyme (ICE) substrate, comprising contacting the substrate with a modified ICE such that the ICE substrate is cleaved, wherein the modified ICE comprises an amino acid sequence having an amino acid corresponding to aspartic acid at position 381 of unmodified ICE (SEQ ID NO:
A method for identifying a modulator of interleukin-1β converting enzyme (ICE) protease activity, comprising:
Dependencies are inferred from the claim text.